论文部分内容阅读
本文报告了静脉点滴右旋糖酐40治疗急性期缺血性脑梗塞的单盲对照试验结果。患者共100例,被随意分为治疗组或对照组。所有患者均在48小时内有过缺血性脑梗塞,并符合下列4项条件:(1)腰穿脑脊液红血球少于500/立方毫米,(2)近一周内无心肌梗塞,(3)无立即抗凝治疗指征(如合并房颤的二尖瓣狭窄),(4)无明显心肾衰竭。治疗组52例,系用静脉点滴右旋糖酐40的5%葡萄糖500毫升,
This article reports the single-blind, controlled trial of intravenous dextran 40 in the treatment of acute ischemic stroke. A total of 100 patients were randomly divided into treatment group or control group. All patients had ischemic cerebral infarction within 48 hours and met the following four conditions: (1) less than 500 / cubic millimeter of cerebrospinal fluid red blood cells in lumbar puncture, (2) no myocardial infarction in the last week, (3) no Immediate anticoagulation therapy indications (such as mitral stenosis with atrial fibrillation), (4) no obvious heart and kidney failure. Treatment group of 52 cases, Department of intravenous dextran 40 40% 5% glucose 500 ml,